A detailed history of Kennedy Capital Management, Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 914,648 shares of ANNX stock, worth $5.99 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
914,648
Previous 774,698 18.07%
Holding current value
$5.99 Million
Previous $5.55 Million 19.32%
% of portfolio
0.1%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $605,983 - $950,260
139,950 Added 18.07%
914,648 $4.48 Million
Q1 2024

May 15, 2024

SELL
$4.03 - $7.81 $1.21 Million - $2.35 Million
-301,032 Reduced 27.98%
774,698 $5.55 Million
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $160,951 - $457,180
98,743 Added 10.11%
1,075,730 $4.88 Million
Q3 2023

Nov 14, 2023

BUY
$2.13 - $3.84 $2.08 Million - $3.75 Million
976,987 New
976,987 $2.31 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.